Einträge von Grabbe, Stephan auf dem Publikationsserver

Becker, Jürgen C, Ugurel, Selma, Leiter, Ulrike, Meier, Friedegund , Gutzmer, Ralf, Haferkamp, Sebastian, Zimmer, Lisa, Livingstone, Elisabeth, Eigentler, Thomas K , Hauschild, Axel, Kiecker, Felix, Hassel, Jessica C, Mohr, Peter, Fluck, Michael, Thomas, Ioannis , Garzarolli, Marlene, Grimmelmann, Imke, Drexler, Konstantin, Spillner, Alexandra N, Eckhardt, Sebastian, Schadendorf, Dirk, van Akkooi, Alexander, van Houdt, Winan, Wilhelm, Tabea, Farmer, Kimberley, Ulrich, Claas, Gambichler, Thilo, Bluhm, Leonie, Schinagl, Heidemarie, Kellner, Ivonne, Herbst, Rudolf, Meiß, Frank, Rafei-Shamsabadi, David, Sell, Sabine, Kaatz, Martin, Wulfken, Lena, Hartmann, Martin, Kähler, Katharina, Ziemer, Mirjana, Simon, Jan, Terheyden, Patrick, Thaci, Diamant, Loquai, Carmen, Mitzel-Rink, Heidrun, Grabbe, Stephan, Stege, Henner, Gaiser, Maria, Utikal, Jochen, Berking, Carola, Heinzerling, Lucie, Schlaak, Max, Tomsitz, Dirk, Dyballa, Jörg, Magnolo, Nina, Weishaupt, Carsten, Berneburg, Mark, Garbe, Claus, Flatz, Lukas, Gesierich, Anja und Schilling, Bastian (2023) Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial. The Lancet 402 (10404), S. 798-808. Volltext nicht vorhanden.

Haist, Maximilian , Stege, Henner, Rogall, Friederike, Tan, Yuqi , von Wasielewski, Imke, Klespe, Kai Christian, Meier, Friedegund , Mohr, Peter, Kähler, Katharina C, Weichenthal, Michael , Hauschild, Axel, Schadendorf, Dirk, Ugurel, Selma, Lodde, Georg, Zimmer, Lisa, Gutzmer, Ralf, Debus, Dirk, Schilling, Bastian, Kreuter, Alexander, Ulrich, Jens, Meiss, Frank , Herbst, Rudolf, Forschner, Andrea, Leiter, Ulrike, Pfoehler, Claudia, Kaatz, Martin, Ziller, Fabian, Hassel, Jessica C, Tronnier, Michael, Sachse, Michael, Dippel, Edgar, Terheyden, Patrick, Berking, Carola, Heppt, Markus V, Kiecker, Felix, Haferkamp, Sebastian, Gebhardt, Christoffer , Simon, Jan Christoph, Grabbe, Stephan und Loquai, Carmen (2023) Treatment management forBRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG. Journal for ImmunoTherapy of Cancer 11 (9), e007630. Volltext nicht vorhanden.

Sohl, Julian, Hartmann, Ann-Kathrin, Hahlbrock, Jennifer, Bartneck, Joschka, Stassen, Michael, Klein, Matthias, Bros, Matthias, Grabbe, Stephan, Marini, Federico , Woods, Kevin, Guezguez, Borhane, Mack, Matthias, Schild, Hansjörg, Muth, Sabine, Melchior, Felix, Probst, Hans Christian, Langguth, Peter und Radsak, Markus P. (2022) Dithranol as novel co-adjuvant for non-invasive dermal vaccination. npj Vaccines 7 (1). Volltext nicht vorhanden.

Haist, Maximilian , Stege, Henner, Lang, Berenice Mareen, Tsochataridou, Aikaterini, Salzmann, Martin, Mohr, Peter, Schadendorf, Dirk, Ugurel, Selma , Placke, Jan-Malte, Weichenthal, Michael , Gutzmer, Ralf , Leiter, Ulrike , Kaatz, Martin, Haferkamp, Sebastian, Berking, Carola, Heppt, Markus , Tschechne, Barbara, Schummer, Patrick, Gebhardt, Christoffer , Grabbe, Stephan und Loquai, Carmen (2022) Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry. Cancers 14 (22), S. 5543. Volltext nicht vorhanden.

Stege, Henner, Haist, Maximilian , Schultheis, Michael, Fleischer, Maria Isabel, Mohr, Peter, Meier, Friedegund, Schadendorf, Dirk, Ugurel, Selma, Livingstone, Elisabeth , Zimmer, Lisa , Herbst, Rudolf, Pföhler, Claudia, Kähler, Katharina, Weichenthal, Michael, Terheyden, Patrick, Nashan, Dorothée, Debus, Dirk, Kaatz, Martin, Ziller, Fabian, Haferkamp, Sebastian , Forschner, Andrea, Leiter, Ulrike, Kreuter, Alexander , Ulrich, Jens, Kleemann, Johannes, Bradfisch, Fabienne, Grabbe, Stephan und Loquai, Carmen (2021) Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma—A Retrospective Multicenter ADOReg Study. Cancers 13 (10), S. 2312. Volltext nicht vorhanden.

Liu, David, Schilling, Bastian , Liu, Derek, Sucker, Antje, Livingstone, Elisabeth, Jerby-Arnon, Livnat, Zimmer, Lisa, Gutzmer, Ralf, Satzger, Imke, Loquai, Carmen, Grabbe, Stephan, Vokes, Natalie, Margolis, Claire A., Conway, Jake, He, Meng Xiao, Elmarakeby, Haitham , Dietlein, Felix, Miao, Diana, Tracy, Adam, Gogas, Helen, Goldinger, Simone M., Utikal, Jochen, Blank, Christian U., Rauschenberg, Ricarda, von Bubnoff, Dagmar, Krackhardt, Angela, Weide, Benjamin, Haferkamp, Sebastian, Kiecker, Felix, Izar, Ben, Garraway, Levi, Regev, Aviv, Flaherty, Keith, Paschen, Annette, Van Allen, Eliezer M. und Schadendorf, Dirk (2019) Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nature Medicine 25 (12), S. 1916-1927. Volltext nicht vorhanden.

Hauschild, Axel, Weichenthal, Michael, Rass, Knuth, Linse, Ruthild, Ulrich, Jens, Stadler, Rudolf, Volkenandt, Matthias, Grabbe, Stephan, Proske, Ulrike, Schadendorf, Dirk, Brockmeyer, Norbert, Vogt, Thomas, Rompel, Rainer, Kaufmann, Roland, Kaatz, Martin, Näher, Helmut, Mohr, Peter, Eigentler, Thomas , Livingstone, Elisabeth und Garbe, Claus (2009) Prospective Randomized Multicenter Adjuvant Dermatologic Cooperative Oncology Group Trial of Low-Dose Interferon Alfa-2b With or Without a Modified High-Dose Interferon Alfa-2b Induction Phase in Patients With Lymph Node–Negative Melanoma. Journal of Clinical Oncology 27 (21), S. 3496-3502. Volltext nicht vorhanden.